New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cogent Biosciences, Inc.
COGT
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

815M

Biotechnology

Next Earning date - 06 May 2025

815M

Biotechnology

Next Earning date - 06 May 2025

7.16USD

Shape-0.13 ( -1.78%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

41
favorite-chart

Volume Buzz

18%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

43%

Quote Panel

Shape
Updated March 23, 2025
1W -3.11 % 1M -4.02 % 3M -8.91 % 1Y 23.88 %

Key Metrics

Shape
  • Market Cap

    815.17M


  • Shares Outstanding

    113.85M


  • Share in Float

    95.39M


  • Dividende

    0


  • Earning Date

    06 May 2025


  • Price Target

    7.16


  • Average Volume

    1.32M


  • Beta

    0.078


  • Range

    5.73-12.61


  • Industry

    Biotechnology


  • Website

    https://www.cogentbio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

COGT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

ShapeNaN%

2025-Revenue

$2.23

Shape-266%

2025-EPS

$909K

Shape101%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

14.00(95.53%)

Number of analyst

1

Last analyst upgrade/downgrade

Scotiabank

initialise

Previous: Not converted

2025-03-07

Now: Outperform

Needham

initialise

Previous: Not converted

2022-12-14

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.54
vs -0.68

Q2.23

arrow
arrow

N/A

-0.59
vs -0.71

Q3.23

arrow
arrow

N/A

-0.64
vs -0.50

Q4.23

arrow
arrow

N/A

-0.63
vs -0.56

Q1.24

arrow
arrow

N/A

-0.62
vs -0.54

Q2.24

arrow
arrow

N/A

-0.59
vs -0.59

Q3.24

arrow
arrow

N/A

-0.64
vs -0.64

Q4.24

arrow
arrow

N/A

-0.09
vs -0.63

Q1.25

arrow
arrow

N/A

-0.58
vs -0.62

Q2.25

arrow
arrow

N/A

-0.57
vs -0.59

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

5.6M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-100%

NA  vs 5.6M

Q1.25

arrow
arrow

NA

179.9K  vs NA

Q2.25

arrow
arrow

NA

588.6K  vs NA

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-15%

-0.15
vs -0.14

Q2.23

arrow
arrow

-13%

-0.13
vs -0.15

Q3.23

arrow
arrow

-18%

-0.18
vs -0.13

Q4.23

arrow
arrow

-21%

-0.21
vs -0.18

Q1.24

arrow
arrow

-14%

-0.14
vs -0.21

Q2.24

arrow
arrow

-16%

-0.16
vs -0.14

Q3.24

arrow
arrow

-22%

-0.22
vs -0.16

Q4.24

arrow
arrow

-27%

-0.27
vs -0.22

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

136

136
vs 136

NA

Q2.23

arrow
arrow

137

137
vs 136

1%

Q3.23

arrow
arrow

138

138
vs 137

1%

Q4.23

arrow
arrow

149

149
vs 138

8%

Q1.24

arrow
arrow

156

156
vs 149

5%

Q2.24

arrow
arrow

152

152
vs 156

-3%

Q3.24

arrow
arrow

164

164
vs 152

8%

Q4.24

arrow
arrow

182

182
vs 164

11%

Earnings Growth

Latest News